Arcus Biosciences Inc (RCUS)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	-307,000	-267,000	53,000	-123,000	-84,710
Revenue	US$ in thousands	117,000	112,000	382,882	77,517	15,000
Net profit margin		-262.39%	-238.39%	13.84%	-158.67%	-564.73%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $-307,000K ÷ $117,000K
= -262.39%

The net profit margin of Arcus Biosciences Inc has been highly volatile over the past five years, swinging from negative to positive and back again. In 2019 and 2020, the company experienced significant losses, with net profit margins of -564.73% and -158.49% respectively, indicating that expenses exceeded revenues by a large margin. In 2021, there was a notable improvement as the net profit margin turned positive at 13.80%, suggesting the company was able to generate a profit relative to its revenue during that period. However, this positive trend was short-lived, as the net profit margin worsened in 2022 and 2023, with values of -238.39% and -262.39% respectively. These negative values indicate that the company's losses continued to exceed its revenues in those years, highlighting potential financial challenges. Overall, the erratic nature of Arcus Biosciences Inc's net profit margin underscores the importance of closely monitoring and managing its expenses and revenue generation strategies to achieve sustainable profitability.